Pharmacogenomic Modeling of Circulating Tumor and Invasive Cells for Prediction of Chemotherapy Response and Resistance in Pancreatic Cancer

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical Cancer Research

• Publication date

  2014-08-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-14-0531PMID 25107917PMCID PMC4346320
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized, multicenter, phase II study of CO-101 versus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma: including a prospective evaluation of the role of hENT1 in gemcitabine or CO-101 sensitivity.

  2013cited by this paper
• Randomized phase III study of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic adenocarcinoma of the pancreas (MPACT).

  2013cited by this paper
• Microarray-based detection and expression analysis of ABC and SLC transporters in drug-resistant ovarian cancer cell lines.

  2013cited by this paper
• Drug transporters in drug efficacy and toxicity.

  2012cited by this paper
• The role of stroma in pancreatic cancer: diagnostic and therapeutic implications

  2012cited by this paper
• Impact of tumor‐associated macrophages on invasive ductal carcinoma of the pancreas head

  2012cited by this paper
• Transcriptional Profiling of Peripheral Blood Mononuclear Cells in Pancreatic Cancer Patients Identifies Novel Genes with Potential Diagnostic Utility

  2011cited by this paper
• FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

  2011influential reference
• Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients

  2010cited by this paper
• Prospective Comparison of Clinical and Genomic Multivariate Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer

  2010cited by this paper
• DNA fingerprinting of the NCI-60 cell line panel

  2009cited by this paper
• Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer.

  2009cited by this paper
• Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer.

  2009cited by this paper
• Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2.

  2008cited by this paper
• A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery

  2007cited by this paper
• The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease

  2006cited by this paper
• Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance.

  2006cited by this paper
• Cytochrome P450 enzymes: novel options for cancer therapeutics.

  2004cited by this paper
• Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy.

  2003cited by this paper
• An Essential Role of Th1 Responses and Interferon-gamma in Infection-Mediated Suppression of Neoplastic Growth

  2003cited by this paper
• New colorimetric cytotoxicity assay for anticancer-drug screening.

  1990cited by this paper

• The Significance of Circulating Tumor Cells in Pancreatic Cancer.

  2024cites this paper
• Advances in Systemic Therapy in Pancreatic Cancer.

  2024cites this paper
• A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in Pancreatic Ductal Adenocarcinoma

  2023cites this paper
• Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer

  2022cites this paper
• Radiation therapy in borderline resectable pancreatic cancer: A review.

  2022cites this paper
• ChemoSensitivity Assay Guided Metronomic Chemotherapy Is Safe and Effective for Treating Advanced Pancreatic Cancer

  2022cites this paper
• Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells

  2022cites this paper
• A Global Systematic Review on Biology, Production Constraints and Uses of Cyperus exculentus L. (Neglected and Underutilized Crop Species): Implications for Valorization.

  2021cites this paper
• Pancreas cancer: Therapeutic trials in metastatic disease

  2021cites this paper
• Liquid Biopsy in Pancreatic Cancer: Are We Ready to Apply It in the Clinical Practice?

  2021cites this paper
• The implication of liquid biopsies to predict chemoresistance in pancreatic cancer

  2021cites this paper
• Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma

  2021cites this paper
• Single Cell Transcriptome in Colorectal Cancer—Current Updates on Its Application in Metastasis, Chemoresistance and the Roles of Circulating Tumor Cells

  2020cites this paper
• The propensity of invasive circulating tumor cells (iCTCs) in metastatic progression and therapeutic responsiveness

  2019cites this paper
• Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2.

  2019cites this paper
• Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer

  2019cites this paper
• Circulating Tumor Cells in Pancreatic Cancer: Current Perspectives

  2019cites this paper
• Circulating Tumor Cells and Cell-Free DNA in Pancreatic Ductal Adenocarcinoma.

  2019cites this paper
• Liquid biopsy in pancreatic cancer: the beginning of a new era

  2018influential citation
• Pancreatic cancer circulating tumor cells: applications for personalized oncology

  2018cites this paper
• Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases?

  2018cites this paper
• Circulating Tumor and Invasive Cell Gene Expression Profile Predicts Treatment Response and Survival in Pancreatic Adenocarcinoma

  2018influential citation
• Multiparameter modalities for the study of patients in the setting of individualized medicine

  2018cites this paper
• Liquid biopsies in gastrointestinal malignancies: when is the big day?

  2018cites this paper
• Current and Emerging Therapies in Pancreatic Cancer

  2018cites this paper
• Targeted Therapies for Pancreatic Cancer

  2018cites this paper
• t(10;14)(q24;q11) TLX1/TRD::t(7;10)(q34;q24) TRB/HOX11

  2018cites this paper
• Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention

  2018cites this paper
• GENETIC EVOLUTION AND PROGNOSTIC DETERMINANTS OF PANCREATIC CANCER ON LONGITUDINAL LIQUID BIOPSIES

  2018cites this paper
• Circulating Tumour Cells

  2017cites this paper
• Preclinical models of pancreatic ductal adenocarcinoma.

  2017cites this paper
• Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategies.

  2017cites this paper
• Perioperative Red Blood Cell Transfusion Is Associated with Poor Long-term Survival in Pancreatic Adenocarcinoma.

  2017cites this paper
• Pharmacogenomics of platinum-based chemotherapy in non-small cell lung cancer: focusing on DNA repair systems

  2017cites this paper
• A phase 2 trial of personalized cytotoxic therapy based on tumor immunohistochemistry in previously treated metastatic pancreatic cancer patients.

  2017cites this paper
• Deep Insight Section

  2017cites this paper
• Internet databases and resources for cytogenetics and cytogenomics

  2017cites this paper
• General resources in Genetics and/or Oncology

  2017cites this paper
• Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality?

  2017cites this paper
• The Study of Pancreatic Circulating Tumor Cells via Isolation with an Integrated Microfluidic Immunomagnetic (IMI) Device

  2016cites this paper
• Current management and future directions in metastatic pancreatic adenocarcinoma

  2016cites this paper
• Circulating Tumor Cells in Gastrointestinal Cancer: Current Practices and Future Directions.

  2016cites this paper
• Using CTCs for pharmacogenomic analysis.

  2016cites this paper
• Molecular and Genetic Basis of Pancreatic Carcinogenesis: Which Concepts May be Clinically Relevant?

  2016cites this paper
• Clinical Significance of Circulating Tumor Cells in Pancreatic Cancer

  2016cites this paper
• Circulating Tumour Cells as an Independent Prognostic Factor in Patients with Advanced Oesophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy

  2016cites this paper
• Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma

  2016cites this paper
• The Selection Strategy for Circulating Tumor Cells (CTCs) Isolation and Enumeration: Technical Features, Methods, and Clinical Applications

  2016cites this paper
• REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

  2016cites this paper
• Individualisierte Therapie beim Pankreaskarzinom

  2016cites this paper
• The emerging complexity of gene fusions in cancer

  2015cites this paper
• Mouse Models of Pancreatic Ductal Adenocarcinoma.

  2015cites this paper
• Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine.

  2015cites this paper
• Pharmacogenomic Modeling in Pancreatic Cancer—Response

  2015cites this paper
• Establishment of pancreatic cancer stem cells by flow cytometry and their biological characteristics.

  2015cites this paper
• Pharmacogenomic Modeling in Pancreatic Cancer—Letter

  2015influential citation
• Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future

  2015cites this paper